The biggest biotech funding rounds in May 2026

The companies Isomorphic Labs, Apogee Therapeutics, and Avalo Therapeutics bagged the biggest biotech funding rounds overall in May 2026 across private and public funding types. In this article, we break down last month’s private and public fundraising activity, looking at the largest rounds in more detail.

IMU Biosciences secures US$53m to decode the immune system

The round was co-led by IQ Capital and Molten Ventures, with participation from the British Business Bank, Meltwind and existing investors. IMU said the new capital will support operational expansion, further development of its clinical platform and infrastructure, and the advancement of clinical programmes in stem cell transplantation, solid organ transplantation and immuno-oncology.

Dammann files for bankruptcy

For the agricultural machinery industry in northern Germany, this move marks a turning point. Dammann has been regarded for decades as a specialist in liquids application. The company’s primary focus is on crop protection technology. In addition, its systems are used in vehicles for winter road maintenance and rail maintenance.

Abivax delivers Phase 3 ulcerative colitis win, but safety concerns trigger market sell-off

Despite what some described as “the best placebo-adjusted clinical remission rates ever for a large Phase 3 study in ulcerative colitis,” analysts focused on emerging safety questions, including reported malignancy cases observed during the trial, sending the company’s shares sharply lower as investors reassessed the overall risk–benefit profile.

THIS Refreshes Wholefood Range with Mushroom “Tofu” and Crunchy Bites

London-based plant-based brand THIS has updated and expanded its wholefood range with two mushroom-based products now rolling out across major UK retailers, responding to consumer demand for cleaner-label, ingredient-led options.

Mahindra growing substantially

Total tractor sales (Domestic + Exports) during May 2026 were at 49,695 units, as against 40,643 units for the same period last year. Exports for the month stood at 1,850 units.

Fulcrum Halts Development of SCD Candidate Pociredir, Sets Strategic Review

Fulcrum Therapeutics said today it is scrapping its lead pipeline program to develop pociredir as a treatment for sickle cell disease (SCD) and launching a “comprehensive” review of strategic alternatives, after the FDA told the company it had heightened concerns about the drug’s risks and benefits in fighting the disease.

巴拉圭本土制造商的视角:以巴拉圭为支点,撬动拉美农化市场增长

拉美农化市场常年被贴上″潜力巨大但门槛复杂″的标签。政策波动、登记周期长、渠道碎片化……真正能走通这条路的企业并不多。但如果有一个市场,既能提供稳定的本地需求,又能作为跳板辐射整个拉丁美洲——巴拉圭正在成为那个答案。

Viva! Crowdfunds UK’s First Dairy Documentary to Counter Industry Messaging

Bristol-based vegan charity Viva! has launched a crowdfunding campaign on World Milk Day to finance what it describes as the UK’s first feature documentary dedicated entirely to the dairy industry. The campaign is seeking £25,000 in public donations, with a further £25,000 in match funding to be unlocked once the initial target is reached.

安道麦在印度推广预防性杀虫剂BAZAK®(吡蚜酮+呋虫胺WDG),应对褐飞虱威胁

世界农化网中文网报道:水稻占印度粮食总产量的40%以上,数以百万计的种植者依赖这一作物维持生计和稳定。然而,褐飞虱(BPH)一直是水稻面临的最具破坏性的威胁之一,严重爆发时可导致高达70%的产量损失。这种快速蔓延的害虫能在数天内毁掉数月劳作,其影响远不止一季收成——作物受损或绝收会威胁农户的经济安全,打乱长期规划,并危及未来几个种植季。